DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)



company name or ticker

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy

StemCells Management Discusses Q4 2012 Results - Earnings Call Transcript

Phase II Trials Will Be Pivotal For These Stem Cell Companies

4 Biotech Stocks Under $5 to Watch

Geron Earnings: An Early Look

Let's look forward to this company's next earnings report.

StemCells' Recent Share Price Drop

Stem Cells Have a Long Way to Go

StemCells produces tantalizing data on its neural stem cell product HuCNS-SC, but don't read too much into it.

Tuesday’s biggest gaining and declining stocks

StemCells Shares Surge Following News of Completion of First Patient Cohort for Spinal Cord Injury T

StemCells Shares Surge Following News of Completion of First Patient Cohort for Spinal Cord Injury Trial

Stem Cell Therapy Companies: Underappreciated Outperformers